Aidigong Maternal & Child Health Limited (Stock Code: 00286) released its monthly return for October 2025. According to the filing, the total authorized share capital remains HKD 808,000,000, comprising 2,000,000,000 ordinary shares at par value HKD 0.4 and a total of 20,000,000 convertible preference shares (Class A and Class B) at par value HKD 0.4.

The company’s issued share capital as of October 31, 2025, consists of 192,183,832 ordinary shares, 4,681,647 Class A convertible preference shares, and 4,681,647 Class B convertible preference shares. These numbers remained unchanged from the previous month.

Regarding share options, the outstanding quantity under the scheme approved on June 28, 2022, totals 10,787,537 options, with no adjustments during the month. The two classes of convertible preference shares (Class A and Class B) recorded no new share issues. Their conversion prices stand at HKD 12.64 and HKD 17.43, respectively, reflecting adjustments following the previous share consolidation and completion of a placing under a specific mandate on November 6, 2024.

Meanwhile, arrangements with Hongchang International Investment Limited and the Share Award Scheme also remain unchanged. The maximum shares issuable under the former agreement total 1,250,000 shares (post-consolidation), and the Share Award Scheme retains a possible issuance of 1,587,500 shares (post-consolidation). No shares were issued, repurchased, or transferred into treasury during October 2025.